|
Re: Earliest minute/hour
|
5
|
Resverlogix Corp.
|
Sep 29, 2019 02:51PM
|
|
Re: Eastern exercised some $0.90 cent warrants
|
3
|
Resverlogix Corp.
|
Aug 10, 2018 02:38AM
|
|
Re: eGFR and Cognition?
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 01:39AM
|
|
Re: eGFR and Cognition?
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 02:40AM
|
|
Re: eGFR and Cognition?
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 10:20AM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 19, 2018 01:18PM
|
|
Re: Eligibility for registered accounts in Canada
|
3
|
Zenith Epigenetics
|
Aug 19, 2018 09:07PM
|
|
Re: EMA
|
3
|
Resverlogix Corp.
|
Jun 10, 2020 05:27PM
|
|
Re: Embargo
|
3
|
Zenith Epigenetics
|
Mar 31, 2017 12:13PM
|
|
Re: Epigenetics and Coronavirus
|
7
|
Resverlogix Corp.
|
Mar 23, 2020 03:31PM
|
|
Re: Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 05:10PM
|
|
Re: Epigenetics in the News
|
2
|
Resverlogix Corp.
|
Sep 08, 2019 04:27AM
|
|
Re: Epizyme market cap $750 mil USd
|
4
|
Zenith Epigenetics
|
Jun 16, 2017 12:38PM
|
|
Re: Equity financing
|
5
|
Zenith Epigenetics
|
Jun 25, 2018 09:01PM
|
|
Re: Equity offering
|
4
|
Zenith Epigenetics
|
Jun 04, 2018 07:05PM
|
|
Re: ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
3
|
Resverlogix Corp.
|
Apr 14, 2019 12:29PM
|
|
Re: ERROR Re: Some wishful thinking....
|
2
|
Resverlogix Corp.
|
Jun 10, 2018 12:28PM
|
|
Re: ERROR Re: Some wishful thinking....
|
4
|
Resverlogix Corp.
|
Jun 11, 2018 01:01AM
|
|
Re: ESC Poster on BETonMACE Design and Baseline Data
|
2
|
Resverlogix Corp.
|
Sep 03, 2019 04:22PM
|
|
Re: ESC Poster on BETonMACE Design and Baseline Data
|
1
|
Resverlogix Corp.
|
Sep 03, 2019 06:21AM
|
